Drug Pricing
Blog
What We’re Watching – June 5
Tim Anaya – Digging Up Ways to Lower Costs for High Value but Expensive Drugs In the latest video in the “Escape the Drug Pricing Maze” video, Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some ...
Agriculture
What We’re Watching – May 22
Rowena Itchon – A Memorial Day Tribute 2020 Kerry Jackson – This Doctor Won’t Take Health Insurance – and Charges Just $35 a Visit Meet the Pittsburgh doctor who doesn’t take health care insurance and charges only $35 for most office visits. That makes him a doctor from a different era. But ...
Blog
What We’re Watching – May 8
Rowena Itchon – Love in the Time of Coronavirus Watch some of our front line medical personnel battling COVID-19 and helping people stay alive take a much-needed break to recreate the iconic scene from Titanic, with an usual, personal protective equipment-themed twist. Kerry Jackson – Dorothy’s Song, COVID-19 Version Somewhere, ...
Coronavirus
Sally Pipes – The Push for Government-Run Health Care During the Coronavirus Crisis
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes is back to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” ...
Blog
What We’re Watching – April 24
Tim Anaya – Taking a Time Machine to a Lower Drug Price Future In the latest video in the “Escape the Drug Pricing Maze” series, Professor Salvare takes Pete Paystoomuch in a time machine to learn how drugs become cheaper after higher initial costs that incentivize innovation. Then they go ...
Blog
COVID-19 Reminds Us That Both Innovation and Affordability Are Needed
In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Blog
What We’re Watching – Good Friday Edition
Tim Anaya – The Crossroads of Innovation and Affordability In the latest “Escape the Drug Pricing Maze” video, On the first step toward escaping the Drug Pricing Maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to ...
Drug Pricing
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Commentary
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Blog
What We’re Watching – March 27
Tim Anaya – Escape the Drug Pricing Maze Watch Professor Salvare guide Pete Paystoomuch through the drug pricing maze, showing how the direction policymakers take on drug pricing policy could impact the affordability and availability of current medicines, and innovation that could lead to future, life-saving cures. Ben Smithwick – ...
What We’re Watching – June 5
Tim Anaya – Digging Up Ways to Lower Costs for High Value but Expensive Drugs In the latest video in the “Escape the Drug Pricing Maze” video, Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some ...
What We’re Watching – May 22
Rowena Itchon – A Memorial Day Tribute 2020 Kerry Jackson – This Doctor Won’t Take Health Insurance – and Charges Just $35 a Visit Meet the Pittsburgh doctor who doesn’t take health care insurance and charges only $35 for most office visits. That makes him a doctor from a different era. But ...
What We’re Watching – May 8
Rowena Itchon – Love in the Time of Coronavirus Watch some of our front line medical personnel battling COVID-19 and helping people stay alive take a much-needed break to recreate the iconic scene from Titanic, with an usual, personal protective equipment-themed twist. Kerry Jackson – Dorothy’s Song, COVID-19 Version Somewhere, ...
Sally Pipes – The Push for Government-Run Health Care During the Coronavirus Crisis
PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes is back to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” ...
What We’re Watching – April 24
Tim Anaya – Taking a Time Machine to a Lower Drug Price Future In the latest video in the “Escape the Drug Pricing Maze” series, Professor Salvare takes Pete Paystoomuch in a time machine to learn how drugs become cheaper after higher initial costs that incentivize innovation. Then they go ...
COVID-19 Reminds Us That Both Innovation and Affordability Are Needed
In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
What We’re Watching – Good Friday Edition
Tim Anaya – The Crossroads of Innovation and Affordability In the latest “Escape the Drug Pricing Maze” video, On the first step toward escaping the Drug Pricing Maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to ...
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
What We’re Watching – March 27
Tim Anaya – Escape the Drug Pricing Maze Watch Professor Salvare guide Pete Paystoomuch through the drug pricing maze, showing how the direction policymakers take on drug pricing policy could impact the affordability and availability of current medicines, and innovation that could lead to future, life-saving cures. Ben Smithwick – ...
